3 Super Dividend Healthcare Stocks: PDL BioPharma, GlaxoSmithKline, AstraZeneca

Page 1 of 2

The financial uncertainty in our debt markets has increased the attractiveness of high dividend stocks. Moreover, international markets are showing no sign of immediate recovery, and financial uncertainty will continue well into 2013. I recommend that investors looking for regular streams of income buy dividend stocks, but only those which have strong fundamentals. The following 3 companies offer a high yield, and analysis shows their dividend is sustainable.

PDL BioPharma Inc. (NASDAQ:PDLI)

PDL BioPharma (NASDAQ:PDLI)

PDL is a little different from other healthcare companies. It is primarily an IP asset management company that aims to distribute wealth through dividends, of its royalty bearing assets. The Nevada-based company offers patents covering different aspects of humanizing antibodies. The company currently offers an 8% dividend yield and has a payout ratio of 43%.

The most interesting aspect of PDL’s dividend is its suitability, due to its unique model. The company basically pays back the royalties it collects in the form of a dividend; therefore it bears no risk itself. The financial position of the company is sound, with the current ratio approximately 30% above the industry average. Moreover, the stock is currently trading at a P/E of 4.7x and a mean sell side price estimate is $6.90. I believe PDL’s dividend is sustainable, and it is a good dividend play.



PDLI data by YCharts

GlaxoSmithKline (NYSE:GSK)

GlaxoSmithKline is one of the world’s largest pharmaceutical companies, and has a market cap of more than $100 billion. The company is involved in the discovery and commercialization of various pharmaceutical products. It offers treatments for HIV, CNS (Central Nervous System) diseases, cardiovascular diseases, metabolic, respiratory diseases, vaccines, etc. GSK has a forward annual dividend yield of 5.2%, which is more than twice industry average and the highest amongst big pharmaceuticals.

On the downside, the payout ratio is pretty high (77%) and the company is also highly leveraged. However, the operating cash flow yield is 5.7% and is above the dividend yield, which shows that at these levels its dividends are sustainable. The stock is currently trading at a P/E of 11.6x, which is well below the NYSE average of 18x and has a 10% upside, based on mean sell side estimates. Therefore I believe it’s a good buy for dividend and capital gains.



GSK data by YCharts

Page 1 of 2

Dividend Stock Alert - Billionaire Robbins' Top Dividend Idea With 70% Upside Potential

Get Paid 3.5% Per Year While Waiting For The Stock Appreciate 70%

Larry Robbins' Glenview Capital Opportunity Fund returned 101.7% in 2013 and Robbins personally made $750 million. The same fund returned 25.3% in 2014. In this FREE REPORT we will share Robbins' top dividend idea that yields 3.5% and has been increasing its dividends for 39 consecutive years. Robbins thinks the stock has the potential to appreciate 70%.

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!